INS and type 1 diabetes mellitus: A second randomized controlled trial (RCT) evaluating different insulin treatments during EN included 50 patients with non-type 1 diabetes who were randomly assigned to receive sliding scale subcutaneous regular insulin either with or without once daily subcutaneous glargine.